Accurate Diagnostic continues to scale up its capacity to meet the growing demand in the local and national markets. Credit: Fernando Zhiminaicela / Pixabay.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the outbreak on our timeline.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Accurate Diagnostic Laboratories is set to launch its immunoglobulin class IgG and IgM antibody testing this week to help the US meet the demand for wider Covid-19 diagnostics.

The lab will initially use the Diazyme testing platform to offer the antibody test.

Earlier this month, Accurate Diagnostic and RUCDR Infinite Biologics developed new collection approach that uses saliva as the primary test biomaterial for Covid-19.

The method enables self-administered sample collection by individuals who are in quarantine or self-isolation.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

With the launch of the new serology Covid-19 diagnostics test, the lab expects to meet both sides of the laboratory testing equation by diagnosing patients with active infection and those who have been infected before.

To continue scaling up its capacity to meet the testing demand in the local and national markets, Accurate Diagnostic is working with its vendor partners.

Accurate Diagnostic Laboratories CEO and owner Rupen Patel said: “While there is still a lot of scientific ambiguity on whether the detection of antibodies confirms that people exposed to Covid-19 have developed an immune response, most believe that antibody testing is a significant part of our fight against the virus.

“There is no playbook for handling this pandemic but I am extremely proud of the Accurate Diagnostic Labs family and all our colleagues in the industry for working tirelessly to do our part by expanding testing.”

Recently, Diazyme has launched Diazyme DZ-Lite SARS-CoV-2 IgG and SARS-CoV-2 IgM CLIA test kits for detecting Covid-19.

They are run on the fully automated Diazyme DZ-Lite 3000 Plus chemiluminescence analyser that Accurate Diagnostics will also use for its immunoglobulin class IgG and IgM antibody testing.